Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Eye Contact Lens. 2023 May 2;49(7):267–274. doi: 10.1097/ICL.0000000000000993

TABLE 2.

Antibiotic Resistance Profiles for Most Common Bacterial Isolates

Organism Number of isolates Antibiotic Number resistant/Number tested Percentage resistance (%)
Coagulase-negative Staphylococcus species 154 Erythromycin 91/154 59.1
Oxacillin 65/154 42.2
Tetracycline 22/153 14.4
Vancomycin 0/153 0
Clindamycin 48/151 31.8
Linezolid 0/26 0
Moxifloxacin 1/4 25
Levofloxacin 1/1 100
Trimethoprim-Sulfamethoxazole 1/1 100
Gentamicin 0/1 0
Cutibacterium (Propionibacterium) species 100 Ciprofloxacin 0/8 0
Penicillin 1/8 12.5
Rifampin 1/8 12.5
Ceftriaxone 0/5 0
Tetracycline 0/5 0
Vancomycin 0/5 0
Moxifloxacin 0/1 0
Pseudomonas aeruginosa 76 Aztreonam 9/75 12
Ciprofloxacin 5/75 6.7
Meropenem 2/75 2.7
Piperacillin-Tazobactam 2/75 2.7
Cefepime 0/75 0
Ceftazidime 0/75 0
Tobramycin 0/75 0
Gentamicin 0/75 0
Imipenem 1/2 50
Levofloxacin 1/1 100
Corynebacterium species 39 Erythromycin 11/18 61.1
Gentamicin 1/18 5.56
Penicillin 4/17 23.5
Ciprofloxacin 2/3 66.7
Moxifloxacin 0/1 0
Viridans group Streptococci 35 Penicillin 2/5 40
Levofloxacin 0/1 0
Linezolid 0/1 0
Daptomycin 0/1 0
Methicillin-susceptible Staphylococcus aureus 30 Erythromycin 13/29 44.8
Clindamycin 12/29 41.3
Tetracycline 2/29 6.9
Trimethoprim-Sulfamethoxazole 1/28 3.6
Daptomycin 0/2 0
Levofloxacin 0/1 0
Methicillin-resistant Staphylococcus aureus 18 Clindamycin 12/18 66.7
Trimethoprim-Sulfamethoxazole 1/18 5.6
Linezolid 0/12 0
Daptomycin 0/2 0
Streptococcus pneumoniae 16 Moxifloxacin 0/16 0
Penicillin 0/16 0
Amoxicillin 0/16 0
Ceftriaxone 0/16 0
Vancomycin 0/16 0
Erythromycin 6/16 37.5
Tetracycline 2/16 12.5
Trimethoprim-Sulfamethoxazole 2/16 12.5
Clindamycin 1/15 67